Accolade, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended November 30, 2022
January 09, 2023 at 09:11 pm
Share
Accolade, Inc. reported earnings results for the third quarter and nine months ended November 30, 2022. For the third quarter, the company reported sales was USD 90.95 million compared to USD 83.45 million a year ago. Net loss was USD 39.87 million compared to net income of USD 22.5 million a year ago. Basic loss per share from continuing operations was USD 0.56 compared to basic earnings per share from continuing operations of USD 0.34 a year ago. Diluted loss per share from continuing operations was USD 0.56 compared to diluted earnings per share from continuing operations of USD 0.31 a year ago.
For the nine months, sales was USD 264.12 million compared to USD 216.27 million a year ago. Net loss was USD 429.22 million compared to USD 88.57 million a year ago. Basic loss per share from continuing operations was USD 6.07 compared to USD 1.41 a year ago. Diluted loss per share from continuing operations was USD 6.07 compared to USD 1.41 a year ago.
Accolade, Inc. provides personalized, technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. Its customers are primarily employers that deploy Accolade solutions in order to provide employees and their families with a single place to turn for their health, healthcare, and benefits needs. It also offers medical opinion services to commercial customers and virtual primary care and mental health support. Its platform, True Health Engine, combines open, cloud-based intelligent technology with multimodal support from a team of empathetic and knowledgeable Accolade Health Assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, womenâs health specialists, case management specialists, expert medical opinion providers, and virtual primary care physicians. Its offerings include Accolade Expert MD, Accolade Care, Plus and Connect and Accolade One.
ACCOLADE, INC. 
